Currently out of the existing stock ratings of Eric Percher, 7 are a HOLD (43.75%), 1 are a SELL (6.25%), 8 are a BUY (50%).
Analyst Eric Percher, currently employed at NEPHRON RESEARCH, has had 66.67% of price targets met with an average potential upside of 18.09%, reached in 938 days on average. Previously, Eric Percher worked at BARCLAYS.
Eric Percher has documented 34 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MCK, McKesson at 19-May-2017.
Analyst best performing recommendations are on CERN (CERNER CORP).
The best stock recommendation documented was for CERN (CERNER CORP) on 1/19/2017. The price target of $52 was fulfilled within 13 days with a profit of $2.04 (4.08%), with a performance score of 3.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Nov-2018
$180
$-155.65 (-46.37%)
7 years 11 months 19 days ago
(27-Nov-2018)
0/1 (0%)
$-4463.45 (-96.12%)
Hold Since 12-Nov-2018
$150
$-185.65 (-55.31%)
8 years 3 days ago
(12-Nov-2018)
0/1 (0%)
$-4468.95 (-96.75%)
Buy Since 12-Nov-2018
$142
$-193.65 (-57.69%)
8 years 3 days ago
(12-Nov-2018)
0/1 (0%)
$-4476.95 (-96.93%)
Hold Since 12-Nov-2018
$160
$-175.65 (-52.33%)
$160
8 years 3 days ago
(12-Nov-2018)
0/2 (0%)
$-4458.95 (-96.54%)
Hold Since 12-Nov-2018
$179
$-156.65 (-46.67%)
$173
8 years 3 days ago
(12-Nov-2018)
0/3 (0%)
$-4439.95 (-96.12%)
What Year was the first public recommendation made by Eric Percher?
